← Back to Search

Behavioral Intervention

Assessments for Delayed Sleep Phase Syndrome

N/A
Recruiting
Led By Kenneth Wright, PhD
Research Sponsored by University of Colorado, Boulder
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Delayed sleep wake phase disorder diagnosis
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up continuously for 1. up to 39 and 2. 23 hours
Awards & highlights

Summary

This trial aims to investigate why some people have delayed sleep wake phase disorder (DSWPD). Researchers will study if individuals with DSWPD have changes in their biological clock and how they respond to light

Who is the study for?
This trial is for individuals diagnosed with delayed sleep wake phase disorder (DSWPD), living at high altitudes like Denver or higher, and have a body mass index (BMI) that's normal to moderately overweight. It excludes those with psychiatric disorders, other sleep disorders, current medication use, or recent medical conditions.
What is being tested?
The study aims to understand DSWPD by comparing circadian rhythms and light sensitivity in patients versus healthy controls. Additionally, it will evaluate a new blood test method designed to predict circadian rhythms.
What are the potential side effects?
Since the interventions involve assessments rather than medications or invasive procedures, significant side effects are not expected. However, discomfort from blood draws or potential eye strain from light sensitivity tests may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with delayed sleep wake phase disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~continuously for 1. up to 39 and 2. 23 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and continuously for 1. up to 39 and 2. 23 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Core body temperature
Glucose
Psychomotor vigilance
+1 more
Secondary outcome measures
Melatonin
Skin temperature

Trial Design

1Treatment groups
Experimental Treatment
Group I: AssessmentExperimental Treatment2 Interventions
Circadian rhythms and light sensitivity

Find a Location

Who is running the clinical trial?

Northwestern UniversityOTHER
1,624 Previous Clinical Trials
937,153 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,834,215 Total Patients Enrolled
University of Colorado, BoulderLead Sponsor
122 Previous Clinical Trials
29,093 Total Patients Enrolled
~44 spots leftby Jul 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top